Insmed Reports Positive Topline Results From Phase 3 ARISE Study Of ARIKAYCE

RTTNews | 693 hari yang lalu
Insmed Reports Positive Topline Results From Phase 3 ARISE Study Of ARIKAYCE

(RTTNews) - Biopharmaceutical company Insmed Inc. (INSM) announced Tuesday positive topline results from its Phase 3 ARISE study of ARIKAYCE in patients with newly diagnosed or recurrent nontuberculous mycobacterial (NTM) lung infection caused by Mycobacterium avium complex (MAC) who had not started antibiotics.

The study met its primary objective of demonstrating that the Quality of Life - Bronchiectasis (QOL-B) respiratory domain works effectively as a patient-reported outcome (PRO) instrument in patients with MAC lung disease.

Based on these results, Insmed plans to propose to the U.S. Food and Drug Administration (FDA) that the QOL-B respiratory domain PRO be the primary endpoint for the ENCORE study without any modifications.

Patients in ARISE were randomized 1:1 to treatment with ARIKAYCE plus macrolide-based background regimen (ARIKAYCE arm) or placebo plus macrolide-based background regimen (comparator arm) for six months, followed by one month off treatment.

Based on the results of ARISE, Insmed plans to explore with global regulators accelerating the filing for approval of ARIKAYCE in newly infected patients with MAC lung disease.

In parallel, the Company continues to enroll patients in ENCORE, which will use the PRO tool that has been validated in ARISE, with 250 patients expected to be enrolled by the end of 2023.

Enrollment in ENCORE is expected to continue into 2024 to ensure a high degree of statistical powering and Insmed anticipates reporting topline data from ENCORE in 2025.

read more
Swiss Market Closes On Firm Note

Swiss Market Closes On Firm Note

The Switzerland market shrugged off a somewhat shaky start and climbed higher on Tuesday with investors mostly reacting to corporate earnings updates, and looking ahead to monetary policy announcement from the Federal Reserve and closely following trade talks.
RTTNews | 2j 25min yang lalu
European Stocks Close Higher As Investors React To Earnings

European Stocks Close Higher As Investors React To Earnings

European stocks closed on a firm note on Tuesday as investors reacted to a slew of earnings announcements from the region, and looked ahead to monetary policy announcements from some leading central banks, including the U.S. Federal Reserve.
RTTNews | 2j 47min yang lalu
TSX Pares Some Gains After Hitting New High; Celestica Rises On Strong Results

TSX Pares Some Gains After Hitting New High; Celestica Rises On Strong Results

The Canadian market is up in positive territory a little past noon on Tuesday, supported by gains in technology, real estate, healthcare and consumer staples sectors. In addition to following the developments on the trade front, investors are also looking ahead to the monetary policy announcements from the Bank of Canada and the Federal Reserve.
RTTNews | 3j 47min yang lalu
U.S. Consumer Confidence Modestly Improves In July

U.S. Consumer Confidence Modestly Improves In July

Consumer confidence in the U.S. saw a modest improvement in the month of July, according to a report released by the Conference Board on Tuesday. The Conference Board said its consumer confidence index rose to 97.2 in July after falling to a revised 95.2 in June.
RTTNews | 6j 5min yang lalu
Bay Street Seen Opening Slightly Higher

Bay Street Seen Opening Slightly Higher

Canadian shares may open higher Tuesday morning, riding on firm oil and metal prices. Investors, awaiting trade talks between Canadian and U.S. officials, also look ahead to Bank of Canada's interest rate decision, due on Wednesday.
RTTNews | 7j 25min yang lalu